Bausch + Lomb
NJ - Bridgewater
neomycin sulfate, polymyxin b sulfate and gramicidin
NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN (neomycin sulfate, polymyxin b sulfate and gramicidin) by Bausch + Lomb is clinical pharmacology a wide range of antibacterial action is provided by the overlapping spectra of neomycin, polymyxin b sulfate, and gramicidin. First approved in 1996.
Drug data last refreshed 1w ago
CLINICAL PHARMACOLOGY A wide range of antibacterial action is provided by the overlapping spectra of neomycin, polymyxin B sulfate, and gramicidin. Neomycin is bactericidal for many gram-positive and gram-negative organisms. It is an aminoglycoside antibiotic which inhibits protein synthesis by…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Worked on NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.